Table 5.
Observed and expected numbers of malignancies and their SIR with 95% CI.
| O/E | SIR | 95% CI | p-Value | |
|---|---|---|---|---|
| JAKi | 12/5.71 | 2.10 | 1.23–2.97 | 0.02* |
| IL-6i | 10/9.21 | 1.09 | 0.56–1.61 | 0.76 |
IL-6i, interleukin-6 receptor inhibitors; JAKi, Janus kinase inhibitors; CI, confidence interval; E, expected number; O, observed number; SIR, standardized incidence ratio.